Table 1.
KEGG Pathway | p-Value | No. of Related Genes |
---|---|---|
hsa-miR-20b-5p | ||
Transcriptional misregulation in cancer | 0.00251 | 5 |
Pathways in cancer | 0.00347 | 11 |
Neurotrophin signaling pathway | 0.00534 | 7 |
Hepatitis B | 0.00786 | 4 |
Sphingolipid signaling pathway | 0.01025 | 6 |
Axon guidance | 0.01727 | 6 |
Chronic myeloid leukemia | 0.01831 | 4 |
Proteoglycans in cancer | 0.01846 | 8 |
MAPK signaling pathway | 0.02168 | 9 |
Renal cell carcinoma | 0.02314 | 4 |
Hepatitis C | 0.02906 | 6 |
Ubiquitin mediated proteolysis | 0.03487 | 6 |
Acute myeloid leukemia | 0.04346 | 3 |
Choline metabolism in cancer | 0.04696 | 5 |
hsa-miR-1252-5p | ||
Metabolism of xenobiotics by cytochrome P450 | 1.38E+03 | 4 |
Lysine degradation | 1.91E+06 | 6 |
Transcriptional misregulation in cancer | 0.00010 | 13 |
Mucin type O-glycan biosynthesis | 0.01004 | 3 |
Glycosphingolipid biosynthesis - globo series | 0.01154 | 3 |
Glycosphingolipid biosynthesis - ganglio series | 0.01174 | 2 |
Proteoglycans in cancer | 0.02550 | 13 |
Note: Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathways Related to the Putative Genes That miR-20b-5p or miR-1252-5p May Be Involved.